The CLSA China Growth Fund LP targets a broad spectrum of professional investors including family offices, ultra high-net-worth individuals and private banks pension funds, as well as endowments, insurance companies, sovereign and supranational funds, fund of funds, and large companies.
The initial closing of the CLSA Capital Partners’ fund took place on 15 February 2022.
“The fund aims to invest in companies with rapid growth in China’s healthcare, TMT, smart manufacturing and renewable energy sectors, which are all burgeoning sectors of strategic importance to this second largest economy in the world,” said CLSA CP.
The fund is well positioned to identify highly sought-after investment opportunities and achieve superior returns for global investors in an ever-changing landscape, it said.
CLSA CP, the shareholder of the general partner and investment manager of the fund, has worked with around 200 US dollar limited partners, including pension funds, insurance companies, and sovereign funds.
CLSA CP currently has over $7bn of assets under management. CLSA CP is part of CLSA, whose parent company is Citic Securities.
